特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

獣医腫瘍学の世界市場:動物タイプ・療法・癌のタイプ・地域別の分析および予測(2020年~2026年)

Global Veterinary Oncology Market By Animal Type By Therapy By Cancer Type By Region, Industry Analysis and Forecast, 2020 - 2026

発行 KBV Research 商品コード 937315
出版日 ページ情報 英文 209 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
獣医腫瘍学の世界市場:動物タイプ・療法・癌のタイプ・地域別の分析および予測(2020年~2026年) Global Veterinary Oncology Market By Animal Type By Therapy By Cancer Type By Region, Industry Analysis and Forecast, 2020 - 2026
出版日: 2020年04月30日 ページ情報: 英文 209 Pages
概要

世界の獣医腫瘍学市場は、予測期間中に13.2%のCAGRで成長する見通しで、2026年には3億6,920万米ドルに達すると予測されています。

当レポートは世界の獣医腫瘍学市場について調査しており、市場の影響や成功戦略、動物タイプ・療法・癌のタイプ・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 市場の範囲と調査手法

第2章 市場概要

  • イントロダクション
  • 市場に影響を与える主な要因

第3章 競合分析

  • KBV Cardinal Matrix
  • 最近の業界全体における戦略的発展
  • 主な成功戦略

第4章 市場分析:動物タイプ別

第5章 市場分析:療法別

  • 化学療法
  • 放射線
  • 手術
  • 免疫療法市場
  • その他

第6章 市場分析:癌のタイプ別

  • リンパ腫
  • 肥満細胞癌
  • 乳腺および扁平上皮癌
  • その他

第7章 市場分析:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • 南米・中東・アフリカ

第8章 企業プロファイル

  • Boehringer Ingelheim International GmbH
  • Karyopharm Therapeutics, Inc.
  • Regeneus Ltd.
  • Elanco Animal Health, Inc.
  • Zoetis, Inc.
  • Varian Medical Systems, Inc.
  • PetCure Oncology, LLC (Accelitech, LLC)
  • AB Science SA
  • Rhizen Pharmaceuticals S.A.
  • 日本全薬工業株式会社
図表

LIST OF TABLES

  • TABLE 1: PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS- VETERINARY ONCOLOGY MARKET
  • TABLE 2: PRODUCT LAUNCHES AND PRODUCT EXPANSIONS- VETERINARY ONCOLOGY MARKET
  • TABLE 3: MERGERS & ACQUISITIONS - VETERINARY ONCOLOGY MARKET
  • TABLE 4: GLOBAL VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 5: GLOBAL VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 6: GLOBAL CANINE MARKET BY REGION, 2016-2019, USD MILLION
  • TABLE 7: GLOBAL CANINE MARKET BY REGION, 2020-2026, USD MILLION
  • TABLE 8: GLOBAL FELINE MARKET BY REGION, 2016-2019, USD MILLION
  • TABLE 9: GLOBAL FELINE MARKET BY REGION, 2020-2026, USD MILLION
  • TABLE 10: GLOBAL VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 11: GLOBAL VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 12: GLOBAL CHEMOTHERAPY MARKET BY REGION, 2016-2019, USD MILLION
  • TABLE 13: GLOBAL CHEMOTHERAPY MARKET BY REGION, 2020-2026, USD MILLION
  • TABLE 14: GLOBAL RADIOLOGY MARKET BY REGION, 2016-2019, USD MILLION
  • TABLE 15: GLOBAL RADIOLOGY MARKET BY REGION, 2020-2026, USD MILLION
  • TABLE 16: GLOBAL SURGERY MARKET BY REGION, 2016-2019, USD MILLION
  • TABLE 17: GLOBAL SURGERY MARKET BY REGION, 2020-2026, USD MILLION
  • TABLE 18: GLOBAL IMMUNOTHERAPY MARKET BY REGION, 2016-2019, USD MILLION
  • TABLE 19: GLOBAL IMMUNOTHERAPY MARKET BY REGION, 2020-2026, USD MILLION
  • TABLE 20: GLOBAL OTHER THERAPY MARKET BY REGION, 2016-2019, USD MILLION
  • TABLE 21: GLOBAL OTHER THERAPY MARKET BY REGION, 2020-2026, USD MILLION
  • TABLE 22: GLOBAL VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 23: GLOBAL VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 24: GLOBAL LYMPHOMA MARKET BY REGION, 2016-2019, USD MILLION
  • TABLE 25: GLOBAL LYMPHOMA MARKET BY REGION, 2020-2026, USD MILLION
  • TABLE 26: GLOBAL MAST CELL CANCER MARKET BY REGION, 2016-2019, USD MILLION
  • TABLE 27: GLOBAL MAST CELL CANCER MARKET BY REGION, 2020-2026, USD MILLION
  • TABLE 28: GLOBAL MAMMARY & SQUAMOUS CELL CANCER MARKET BY REGION, 2016-2019, USD MILLION
  • TABLE 29: GLOBAL MAMMARY & SQUAMOUS CELL CANCER MARKET BY REGION, 2020-2026, USD MILLION
  • TABLE 30: GLOBAL OTHERS MARKET BY REGION, 2016-2019, USD MILLION
  • TABLE 31: GLOBAL OTHERS MARKET BY REGION, 2020-2026, USD MILLION
  • TABLE 32: GLOBAL VETERINARY ONCOLOGY MARKET BY REGION, 2016-2019, USD MILLION
  • TABLE 33: GLOBAL VETERINARY ONCOLOGY MARKET BY REGION, 2020-2026, USD MILLION
  • TABLE 34: NORTH AMERICA VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 35: NORTH AMERICA VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 36: NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 37: NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 38: NORTH AMERICA CANINE MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 39: NORTH AMERICA CANINE MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 40: NORTH AMERICA FELINE MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 41: NORTH AMERICA FELINE MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 42: NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 43: NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 44: NORTH AMERICA CHEMOTHERAPY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 45: NORTH AMERICA CHEMOTHERAPY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 46: NORTH AMERICA RADIOLOGY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 47: NORTH AMERICA RADIOLOGY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 48: NORTH AMERICA SURGERY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 49: NORTH AMERICA SURGERY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 50: NORTH AMERICA IMMUNOTHERAPY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 51: NORTH AMERICA IMMUNOTHERAPY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 52: NORTH AMERICA OTHER THERAPY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 53: NORTH AMERICA OTHER THERAPY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 54: NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 55: NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 56: NORTH AMERICA LYMPHOMA MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 57: NORTH AMERICA LYMPHOMA MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 58: NORTH AMERICA MAST CELL CANCER MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 59: NORTH AMERICA MAST CELL CANCER MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 60: NORTH AMERICA MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 61: NORTH AMERICA MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 62: NORTH AMERICA OTHERS MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 63: NORTH AMERICA OTHERS MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 64: NORTH AMERICA VETERINARY ONCOLOGY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 65: NORTH AMERICA VETERINARY ONCOLOGY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 66: US VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 67: US VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 68: US VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 69: US VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 70: US VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 71: US VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 72: US VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 73: US VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 74: CANADA VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 75: CANADA VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 76: CANADA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 77: CANADA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 78: CANADA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 79: CANADA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 80: CANADA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 81: CANADA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 82: MEXICO VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 83: MEXICO VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 84: MEXICO VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 85: MEXICO VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 86: MEXICO VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 87: MEXICO VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 88: MEXICO VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 89: MEXICO VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 90: REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 91: REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 92: REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 93: REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 94: REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 95: REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 96: REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 97: REST OF NORTH AMERICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 98: EUROPE VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 99: EUROPE VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 100: EUROPE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 101: EUROPE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 102: EUROPE CANINE MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 103: EUROPE CANINE MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 104: EUROPE FELINE MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 105: EUROPE FELINE MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 106: EUROPE VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 107: EUROPE VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 108: EUROPE CHEMOTHERAPY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 109: EUROPE CHEMOTHERAPY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 110: EUROPE RADIOLOGY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 111: EUROPE RADIOLOGY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 112: EUROPE SURGERY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 113: EUROPE SURGERY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 114: EUROPE IMMUNOTHERAPY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 115: EUROPE IMMUNOTHERAPY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 116: EUROPE OTHER THERAPY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 117: EUROPE OTHER THERAPY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 118: EUROPE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 119: EUROPE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 120: EUROPE LYMPHOMA MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 121: EUROPE LYMPHOMA MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 122: EUROPE MAST CELL CANCER MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 123: EUROPE MAST CELL CANCER MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 124: EUROPE MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 125: EUROPE MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 126: EUROPE OTHERS MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 127: EUROPE OTHERS MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 128: EUROPE VETERINARY ONCOLOGY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 129: EUROPE VETERINARY ONCOLOGY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 130: GERMANY VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 131: GERMANY VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 132: GERMANY VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 133: GERMANY VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 134: GERMANY VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 135: GERMANY VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 136: GERMANY VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 137: GERMANY VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 138: UK VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 139: UK VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 140: UK VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 141: UK VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 142: UK VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 143: UK VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 144: UK VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 145: UK VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 146: FRANCE VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 147: FRANCE VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 148: FRANCE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 149: FRANCE VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 150: FRANCE VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 151: FRANCE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 152: FRANCE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 153: RUSSIA VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 154: RUSSIA VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 155: RUSSIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 156: RUSSIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 157: RUSSIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 158: RUSSIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 159: RUSSIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 160: RUSSIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 161: SPAIN VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 162: SPAIN VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 163: SPAIN VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 164: SPAIN VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 165: SPAIN VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 166: SPAIN VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 167: SPAIN VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 168: SPAIN VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 169: ITALY VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 170: ITALY VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 171: ITALY VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 172: ITALY VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 173: ITALY VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 174: ITALY VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 175: ITALY VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 176: ITALY VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 177: REST OF EUROPE VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 178: REST OF EUROPE VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 179: REST OF EUROPE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 180: REST OF EUROPE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 181: REST OF EUROPE VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 182: REST OF EUROPE VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 183: REST OF EUROPE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 184: REST OF EUROPE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 185: ASIA PACIFIC VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 186: ASIA PACIFIC VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 187: ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 188: ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 189: ASIA PACIFIC CANINE MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 190: ASIA PACIFIC CANINE MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 191: ASIA PACIFIC FELINE MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 192: ASIA PACIFIC FELINE MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 193: ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 194: ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 195: ASIA PACIFIC CHEMOTHERAPY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 196: ASIA PACIFIC CHEMOTHERAPY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 197: ASIA PACIFIC RADIOLOGY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 198: ASIA PACIFIC RADIOLOGY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 199: ASIA PACIFIC SURGERY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 200: ASIA PACIFIC SURGERY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 201: ASIA PACIFIC IMMUNOTHERAPY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 202: ASIA PACIFIC IMMUNOTHERAPY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 203: ASIA PACIFIC OTHER THERAPY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 204: ASIA PACIFIC OTHER THERAPY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 205: ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 206: ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 207: ASIA PACIFIC LYMPHOMA MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 208: ASIA PACIFIC LYMPHOMA MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 209: ASIA PACIFIC MAST CELL CANCER MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 210: ASIA PACIFIC MAST CELL CANCER MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 211: ASIA PACIFIC MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 212: ASIA PACIFIC MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 213: ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 214: ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 215: ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 216: ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 217: CHINA VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 218: CHINA VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 219: CHINA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 220: CHINA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 221: CHINA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 222: CHINA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 223: CHINA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 224: CHINA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 225: JAPAN VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 226: JAPAN VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 227: JAPAN VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 228: JAPAN VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 229: JAPAN VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 230: JAPAN VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 231: JAPAN VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 232: JAPAN VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 233: INDIA VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 234: INDIA VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 235: INDIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 236: INDIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 237: INDIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 238: INDIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 239: INDIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 240: INDIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 241: SOUTH KOREA VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 242: SOUTH KOREA VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 243: SOUTH KOREA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 244: SOUTH KOREA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 245: SOUTH KOREA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 246: SOUTH KOREA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 247: SOUTH KOREA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 248: SOUTH KOREA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 249: SINGAPORE VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 250: SINGAPORE VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 251: SINGAPORE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 252: SINGAPORE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 253: SINGAPORE VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 254: SINGAPORE VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 255: SINGAPORE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 256: SINGAPORE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 257: MALAYSIA VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 258: MALAYSIA VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 259: MALAYSIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 260: MALAYSIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 261: MALAYSIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 262: MALAYSIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 263: MALAYSIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 264: MALAYSIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 265: REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 266: REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 267: REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 268: REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 269: REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 270: REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 271: REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 272: REST OF ASIA PACIFIC VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 273: LAMEA VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 274: LAMEA VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 275: LAMEA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 276: LAMEA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 277: LAMEA CANINE MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 278: LAMEA CANINE MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 279: LAMEA FELINE MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 280: LAMEA FELINE MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 281: LAMEA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 282: LAMEA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 283: LAMEA CHEMOTHERAPY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 284: LAMEA CHEMOTHERAPY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 285: LAMEA RADIOLOGY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 286: LAMEA RADIOLOGY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 287: LAMEA SURGERY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 288: LAMEA SURGERY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 289: LAMEA IMMUNOTHERAPY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 290: LAMEA IMMUNOTHERAPY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 291: LAMEA OTHER THERAPY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 292: LAMEA OTHER THERAPY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 293: LAMEA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 294: LAMEA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 295: LAMEA LYMPHOMA MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 296: LAMEA LYMPHOMA MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 297: LAMEA MAST CELL CANCER MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 298: LAMEA MAST CELL CANCER MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 299: LAMEA MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 300: LAMEA MAMMARY & SQUAMOUS CELL CANCER MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 301: LAMEA OTHERS MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 302: LAMEA OTHERS MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 303: LAMEA VETERINARY ONCOLOGY MARKET BY COUNTRY, 2016-2019, USD MILLION
  • TABLE 304: LAMEA VETERINARY ONCOLOGY MARKET BY COUNTRY, 2020-2026, USD MILLION
  • TABLE 305: BRAZIL VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 306: BRAZIL VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 307: BRAZIL VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 308: BRAZIL VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 309: BRAZIL VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 310: BRAZIL VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 311: BRAZIL VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 312: BRAZIL VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 313: ARGENTINA VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 314: ARGENTINA VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 315: ARGENTINA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 316: ARGENTINA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 317: ARGENTINA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 318: ARGENTINA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 319: ARGENTINA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 320: ARGENTINA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 321: UAE VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 322: UAE VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 323: UAE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 324: UAE VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 325: UAE VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 326: UAE VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 327: UAE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 328: UAE VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 329: SAUDI ARABIA VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 330: SAUDI ARABIA VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 331: SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 332: SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 333: SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 334: SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 335: SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 336: SAUDI ARABIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 337: SOUTH AFRICA VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 338: SOUTH AFRICA VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 339: SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 340: SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 341: SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 342: SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 343: SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 344: SOUTH AFRICA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 345: NIGERIA VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 346: NIGERIA VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 347: NIGERIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 348: NIGERIA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 349: NIGERIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 350: NIGERIA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 351: NIGERIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 352: NIGERIA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 353: REST OF LAMEA VETERINARY ONCOLOGY MARKET, 2016-2019, USD MILLION
  • TABLE 354: REST OF LAMEA VETERINARY ONCOLOGY MARKET, 2020-2026, USD MILLION
  • TABLE 355: REST OF LAMEA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2016-2019, USD MILLION
  • TABLE 356: REST OF LAMEA VETERINARY ONCOLOGY MARKET BY ANIMAL TYPE, 2020-2026, USD MILLION
  • TABLE 357: REST OF LAMEA VETERINARY ONCOLOGY MARKET BY THERAPY, 2016-2019, USD MILLION
  • TABLE 358: REST OF LAMEA VETERINARY ONCOLOGY MARKET BY THERAPY, 2020-2026, USD MILLION
  • TABLE 359: REST OF LAMEA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2016-2019, USD MILLION
  • TABLE 360: REST OF LAMEA VETERINARY ONCOLOGY MARKET BY CANCER TYPE, 2020-2026, USD MILLION
  • TABLE 361: KEY INFORMATION - BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • TABLE 362: KEY INFORMATION - KARYOPHARM THERAPEUTICS, INC.
  • TABLE 363: KEY INFORMATION - REGENEUS LTD.
  • TABLE 364: KEY INFORMATION - ELANCO ANIMAL HEALTH, INC.
  • TABLE 365: KEY INFORMATION - ZOETIS, INC.
  • TABLE 366: KEY INFORMATION --VARIAN MEDICAL SYSTEMS, INC.
  • TABLE 367: KEY INFORMATION - PETCURE ONCOLOGY, LLC
  • TABLE 368: KEY INFORMATION - AB SCIENCE SA
  • TABLE 369: KEY INFORMATION - RHIZEN PHARMACEUTICALS S.A.
  • TABLE 370: KEY INFORMATION - NIPPON ZENYAKU KOGYO CO., LTD.

LIST OF FIGURES

  • FIG 1: METHODOLOGY FOR THE RESEARCH
  • FIG 2: KBV CARDINAL MATRIX
  • FIG 3: KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
  • FIG 4: KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS : 2016, SEP - 2019, NOV) LEADING PLAYERS
  • FIG 5: RECENT STRATEGIES AND DEVELOPMENTS: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • FIG 6: RECENT STRATEGIES AND DEVELOPMENTS: VARIAN MEDICAL SYSTEMS, INC.
目次

The Global Veterinary oncology Market size is expected to reach $369.2 Million by 2026, rising at a market growth of 13.2% CAGR during the forecast period. Cancer is one of the main causes of morbidity in veterinary patients and one of the most important surgical procedures undertaken by veterinarians is the surgical removal of tumors. The annual physical examination plays a crucial role in the diagnosis of neoplasia, either specifically through palpation or through paraneoplastic syndromes that can be detected on regular blood and urine analysis. The physical examination allows for the diagnosis of the involvement of cancers and the identification of concurrent conditions that can affect the treatment plan.

When a tumor is identified, the vet records its size, location, and gross appearance, and palpate regional lymph nodes. The suspicion of a metastatic neoplasm rises as the lymph nodes are swollen, solid, or immovable; however, normal lymph node palpation does not guarantee a lack of metastasis. Hence in most cases, some form of biopsy of the lymph node is recommended.

Intralesional, or debulking, surgery is incomplete resection of a tumor (within the pseudo capsule) with the residual gross disease. It is rarely an appropriate cure for neoplastic diseases, be it benign or malignant. This procedure leaves a tumor cell strain that is often too large, even with adjunctive therapies, such as radiation therapy and chemotherapy, to achieve a successful outcome.

Cancer is prevalent in dogs and in recent years, chemotherapy has progressed dramatically with canine oncology becoming a practice in many countries like the UK, Australia, and the US. However, there were no large-scale trials of the potential side effects of chemotherapeutic drugs in associated animals and very little debate on the ethics of using chemotherapy in these species. In general, the prognosis for animals suffering from malignant neoplasia (which can be conducive to chemotherapy) remains low, and the role of oncology in veterinary medicine can be debated.

Based on Animal Type, the market is segmented into Canine and Feline. Based on Therapy, the market is segmented into Chemotherapy, Radiology, Surgery, Immunotherapy and Others. Based on Cancer Type, the market is segmented into Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Others. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Karyopharm Therapeutics, Inc., Regeneus Ltd., Elanco Animal Health, Inc., Zoetis, Inc., Varian Medical Systems, Inc., PetCure Oncology, LLC (Accelitech, LLC), AB Science SA, Rhizen Pharmaceuticals S.A., and Nippon Zenyaku Kogyo Co., Ltd.

Strategies deployed in Veterinary Oncology Market

Nov-2019: Varian Medical Systems came into partnership with VCA Animal Hospitals. The partnership was announced as a part of the company's newly launched network of VCA Pet CancerCare Centers across North America for providing advanced pet cancer radiotherapy treatment at its specialty hospitals.

Aug-2019: Elanco Animal Health Inc. signed an agreement to acquire Bayer AG's animal-health unit. The acquisition would strengthen Elanco's Animal Health business.

Aug-2019: Boehringer Ingelheim signed partnership agreement with The University of Texas MD Anderson Cancer Center. The partnership was focused on conducting collaborative research to rapidly advance therapies for various types of cancers, including gastrointestinal and lung cancers.

Jul-2019: Boehringer Ingelheim took over AMAL Therapeutics, a biotechnology company focused on cancer immunotherapy. The acquisition helped the company to become an innovator of novel cancer therapies, including immuno-oncology treatments.

Jul-2019: Elanco Animal Health completed the acquisition of Aratana Therapeutics. The acquisition complemented Elanco's field presence and capitalized on new opportunities for Elanco pet therapy brands.

Jun-2019: Varian acquired Endocare and Alicon. The acquisition broadened its portfolio of multidisciplinary integrated cancer care solutions.

Jun-2018: Zoetis teamed up with Regeneron Pharmaceuticals. Through this collaboration, the companies aimed to research the use of Regeneron's monoclonal antibody therapeutics in animals and discover new veterinary treatments.

Jul-2017: PetCure Oncology collaborated with Varian Medical Systems. The collaboration was aimed at bringing a different level of care to pets suffering from cancer. Under this collaboration, the Varian's software suite, including the RapidPlan and ARIA platforms were integrated across PetCure Oncology's national network of veterinary cancer care centers.

May-2017: Karyopharm Therapeutics signed a licensing agreement with Anivive Lifesciences, a biotech company focused on innovations in the veterinary drug and bioinformatics space. Following this agreement, the latter company got the exclusive rights from Karyopharm to research, develop, and commercialize verdinexor (KPT-335) for the treatment of cancer in companion animals.

May-2017: Varian Medical Systems launched the Halcyon system, a new device for cancer treatment. Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity-modulated radiotherapy (IMRT). This new treatment system has been designed for expanding the availability of high-quality cancer care and help save the lives of millions more cancer patients

Scope of the Study

Market Segmentation:

By Animal Type

Canine and

Feline

By Therapy

Chemotherapy

Radiology

Surgery

Immunotherapy and

Others

By Cancer Type

Lymphoma

Mast Cell Cancer

Mammary & Squamous Cell Cancer and

Others

By Geography

North America

US

Canada

Mexico

Rest of North America

Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

Companies Profiled:

Boehringer Ingelheim International GmbH

Karyopharm Therapeutics, Inc.

Regeneus Ltd.

Elanco Animal Health, Inc.

Zoetis, Inc.

Varian Medical Systems, Inc.

PetCure Oncology, LLC (Accelitech, LLC)

AB Science SA

Rhizen Pharmaceuticals S.A.

Nippon Zenyaku Kogyo Co., Ltd.

Unique Offerings from KBV Research:

Exhaustive coverage

Highest number of market tables and figures

Subscription based model available

Guaranteed best price

Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Veterinary Oncology Market, by Animal Type
    • 1.4.2 Global Veterinary Oncology Market, by Therapy
    • 1.4.3 Global Veterinary Oncology Market, by Cancer Type
    • 1.4.4 Global Veterinary Oncology Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Mergers & Acquisitions
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Sep - 2019, Nov) Leading Players

Chapter 4. Global Veterinary Oncology Market by Animal Type

  • 4.1 Global Canine Market by Region
  • 4.2 Global Feline Market by Region

Chapter 5. Global Veterinary Oncology Market by Therapy

  • 5.1 Global Chemotherapy Market by Region
  • 5.2 Global Radiology Market by Region
  • 5.3 Global Surgery Market by Region
  • 5.4 Global Immunotherapy Market by Region
  • 5.5 Global Other Therapy Market by Region

Chapter 6. Global Veterinary Oncology Market by Cancer Type

  • 6.1 Global Lymphoma Market by Region
  • 6.2 Global Mast Cell Cancer Market by Region
  • 6.3 Global Mammary & Squamous Cell Cancer Market by Region
  • 6.4 Global Others Market by Region

Chapter 7. Global Veterinary Oncology Market by Region

  • 7.1 North America Veterinary Oncology Market
    • 7.1.1 North America Veterinary Oncology Market by Animal Type
      • 7.1.1.1 North America Canine Market by Country
      • 7.1.1.2 North America Feline Market by Country
    • 7.1.2 North America Veterinary Oncology Market by Therapy
      • 7.1.2.1 North America Chemotherapy Market by Country
      • 7.1.2.2 North America Radiology Market by Country
      • 7.1.2.3 North America Surgery Market by Country
      • 7.1.2.4 North America Immunotherapy Market by Country
      • 7.1.2.5 North America Other Therapy Market by Country
    • 7.1.3 North America Veterinary Oncology Market by Cancer Type
      • 7.1.3.1 North America Lymphoma Market by Country
      • 7.1.3.2 North America Mast Cell Cancer Market by Country
      • 7.1.3.3 North America Mammary & Squamous Cell Cancer Market by Country
      • 7.1.3.4 North America Others Market by Country
    • 7.1.4 North America Veterinary Oncology Market by Country
      • 7.1.4.1 US Veterinary Oncology Market
        • 7.1.4.1.1 US Veterinary Oncology Market by Animal Type
        • 7.1.4.1.2 US Veterinary Oncology Market by Therapy
        • 7.1.4.1.3 US Veterinary Oncology Market by Cancer Type
      • 7.1.4.2 Canada Veterinary Oncology Market
        • 7.1.4.2.1 Canada Veterinary Oncology Market by Animal Type
        • 7.1.4.2.2 Canada Veterinary Oncology Market by Therapy
        • 7.1.4.2.3 Canada Veterinary Oncology Market by Cancer Type
      • 7.1.4.3 Mexico Veterinary Oncology Market
        • 7.1.4.3.1 Mexico Veterinary Oncology Market by Animal Type
        • 7.1.4.3.2 Mexico Veterinary Oncology Market by Therapy
        • 7.1.4.3.3 Mexico Veterinary Oncology Market by Cancer Type
      • 7.1.4.4 Rest of North America Veterinary Oncology Market
        • 7.1.4.4.1 Rest of North America Veterinary Oncology Market by Animal Type
        • 7.1.4.4.2 Rest of North America Veterinary Oncology Market by Therapy
        • 7.1.4.4.3 Rest of North America Veterinary Oncology Market by Cancer Type
  • 7.2 Europe Veterinary Oncology Market
    • 7.2.1 Europe Veterinary Oncology Market by Animal Type
      • 7.2.1.1 Europe Canine Market by Country
      • 7.2.1.2 Europe Feline Market by Country
    • 7.2.2 Europe Veterinary Oncology Market by Therapy
      • 7.2.2.1 Europe Chemotherapy Market by Country
      • 7.2.2.2 Europe Radiology Market by Country
      • 7.2.2.3 Europe Surgery Market by Country
      • 7.2.2.4 Europe Immunotherapy Market by Country
      • 7.2.2.5 Europe Other Therapy Market by Country
    • 7.2.3 Europe Veterinary Oncology Market by Cancer Type
      • 7.2.3.1 Europe Lymphoma Market by Country
      • 7.2.3.2 Europe Mast Cell Cancer Market by Country
      • 7.2.3.3 Europe Mammary & Squamous Cell Cancer Market by Country
      • 7.2.3.4 Europe Others Market by Country
    • 7.2.4 Europe Veterinary Oncology Market by Country
      • 7.2.4.1 Germany Veterinary Oncology Market
        • 7.2.4.1.1 Germany Veterinary Oncology Market by Animal Type
        • 7.2.4.1.2 Germany Veterinary Oncology Market by Therapy
        • 7.2.4.1.3 Germany Veterinary Oncology Market by Cancer Type
      • 7.2.4.2 UK Veterinary Oncology Market
        • 7.2.4.2.1 UK Veterinary Oncology Market by Animal Type
        • 7.2.4.2.2 UK Veterinary Oncology Market by Therapy
        • 7.2.4.2.3 UK Veterinary Oncology Market by Cancer Type
      • 7.2.4.3 France Veterinary Oncology Market
        • 7.2.4.3.1 France Veterinary Oncology Market by Animal Type
        • 7.2.4.3.2 France Veterinary Oncology Market by Therapy
        • 7.2.4.3.3 France Veterinary Oncology Market by Cancer Type
      • 7.2.4.4 Russia Veterinary Oncology Market
        • 7.2.4.4.1 Russia Veterinary Oncology Market by Animal Type
        • 7.2.4.4.2 Russia Veterinary Oncology Market by Therapy
        • 7.2.4.4.3 Russia Veterinary Oncology Market by Cancer Type
      • 7.2.4.5 Spain Veterinary Oncology Market
        • 7.2.4.5.1 Spain Veterinary Oncology Market by Animal Type
        • 7.2.4.5.2 Spain Veterinary Oncology Market by Therapy
        • 7.2.4.5.3 Spain Veterinary Oncology Market by Cancer Type
      • 7.2.4.6 Italy Veterinary Oncology Market
        • 7.2.4.6.1 Italy Veterinary Oncology Market by Animal Type
        • 7.2.4.6.2 Italy Veterinary Oncology Market by Therapy
        • 7.2.4.6.3 Italy Veterinary Oncology Market by Cancer Type
      • 7.2.4.7 Rest of Europe Veterinary Oncology Market
        • 7.2.4.7.1 Rest of Europe Veterinary Oncology Market by Animal Type
        • 7.2.4.7.2 Rest of Europe Veterinary Oncology Market by Therapy
        • 7.2.4.7.3 Rest of Europe Veterinary Oncology Market by Cancer Type
  • 7.3 Asia Pacific Veterinary Oncology Market
    • 7.3.1 Asia Pacific Veterinary Oncology Market by Animal Type
      • 7.3.1.1 Asia Pacific Canine Market by Country
      • 7.3.1.2 Asia Pacific Feline Market by Country
    • 7.3.2 Asia Pacific Veterinary Oncology Market by Therapy
      • 7.3.2.1 Asia Pacific Chemotherapy Market by Country
      • 7.3.2.2 Asia Pacific Radiology Market by Country
      • 7.3.2.3 Asia Pacific Surgery Market by Country
      • 7.3.2.4 Asia Pacific Immunotherapy Market by Country
      • 7.3.2.5 Asia Pacific Other Therapy Market by Country
    • 7.3.3 Asia Pacific Veterinary Oncology Market by Cancer Type
      • 7.3.3.1 Asia Pacific Lymphoma Market by Country
      • 7.3.3.2 Asia Pacific Mast Cell Cancer Market by Country
      • 7.3.3.3 Asia Pacific Mammary & Squamous Cell Cancer Market by Country
      • 7.3.3.4 Asia Pacific Others Market by Country
    • 7.3.4 Asia Pacific Veterinary Oncology Market by Country
      • 7.3.4.1 China Veterinary Oncology Market
        • 7.3.4.1.1 China Veterinary Oncology Market by Animal Type
        • 7.3.4.1.2 China Veterinary Oncology Market by Therapy
        • 7.3.4.1.3 China Veterinary Oncology Market by Cancer Type
      • 7.3.4.2 Japan Veterinary Oncology Market
        • 7.3.4.2.1 Japan Veterinary Oncology Market by Animal Type
        • 7.3.4.2.2 Japan Veterinary Oncology Market by Therapy
        • 7.3.4.2.3 Japan Veterinary Oncology Market by Cancer Type
      • 7.3.4.3 India Veterinary Oncology Market
        • 7.3.4.3.1 India Veterinary Oncology Market by Animal Type
        • 7.3.4.3.2 India Veterinary Oncology Market by Therapy
        • 7.3.4.3.3 India Veterinary Oncology Market by Cancer Type
      • 7.3.4.4 South Korea Veterinary Oncology Market
        • 7.3.4.4.1 South Korea Veterinary Oncology Market by Animal Type
        • 7.3.4.4.2 South Korea Veterinary Oncology Market by Therapy
        • 7.3.4.4.3 South Korea Veterinary Oncology Market by Cancer Type
      • 7.3.4.5 Singapore Veterinary Oncology Market
        • 7.3.4.5.1 Singapore Veterinary Oncology Market by Animal Type
        • 7.3.4.5.2 Singapore Veterinary Oncology Market by Therapy
        • 7.3.4.5.3 Singapore Veterinary Oncology Market by Cancer Type
      • 7.3.4.6 Malaysia Veterinary Oncology Market
        • 7.3.4.6.1 Malaysia Veterinary Oncology Market by Animal Type
        • 7.3.4.6.2 Malaysia Veterinary Oncology Market by Therapy
        • 7.3.4.6.3 Malaysia Veterinary Oncology Market by Cancer Type
      • 7.3.4.7 Rest of Asia Pacific Veterinary Oncology Market
        • 7.3.4.7.1 Rest of Asia Pacific Veterinary Oncology Market by Animal Type
        • 7.3.4.7.2 Rest of Asia Pacific Veterinary Oncology Market by Therapy
        • 7.3.4.7.3 Rest of Asia Pacific Veterinary Oncology Market by Cancer Type
  • 7.4 LAMEA Veterinary Oncology Market
    • 7.4.1 LAMEA Veterinary Oncology Market by Animal Type
      • 7.4.1.1 LAMEA Canine Market by Country
      • 7.4.1.2 LAMEA Feline Market by Country
    • 7.4.2 LAMEA Veterinary Oncology Market by Therapy
      • 7.4.2.1 LAMEA Chemotherapy Market by Country
      • 7.4.2.2 LAMEA Radiology Market by Country
      • 7.4.2.3 LAMEA Surgery Market by Country
      • 7.4.2.4 LAMEA Immunotherapy Market by Country
      • 7.4.2.5 LAMEA Other Therapy Market by Country
    • 7.4.3 LAMEA Veterinary Oncology Market by Cancer Type
      • 7.4.3.1 LAMEA Lymphoma Market by Country
      • 7.4.3.2 LAMEA Mast Cell Cancer Market by Country
      • 7.4.3.3 LAMEA Mammary & Squamous Cell Cancer Market by Country
      • 7.4.3.4 LAMEA Others Market by Country
    • 7.4.4 LAMEA Veterinary Oncology Market by Country
      • 7.4.4.1 Brazil Veterinary Oncology Market
        • 7.4.4.1.1 Brazil Veterinary Oncology Market by Animal Type
        • 7.4.4.1.2 Brazil Veterinary Oncology Market by Therapy
        • 7.4.4.1.3 Brazil Veterinary Oncology Market by Cancer Type
      • 7.4.4.2 Argentina Veterinary Oncology Market
        • 7.4.4.2.1 Argentina Veterinary Oncology Market by Animal Type
        • 7.4.4.2.2 Argentina Veterinary Oncology Market by Therapy
        • 7.4.4.2.3 Argentina Veterinary Oncology Market by Cancer Type
      • 7.4.4.3 UAE Veterinary Oncology Market
        • 7.4.4.3.1 UAE Veterinary Oncology Market by Animal Type
        • 7.4.4.3.2 UAE Veterinary Oncology Market by Therapy
        • 7.4.4.3.3 UAE Veterinary Oncology Market by Cancer Type
      • 7.4.4.4 Saudi Arabia Veterinary Oncology Market
        • 7.4.4.4.1 Saudi Arabia Veterinary Oncology Market by Animal Type
        • 7.4.4.4.2 Saudi Arabia Veterinary Oncology Market by Therapy
        • 7.4.4.4.3 Saudi Arabia Veterinary Oncology Market by Cancer Type
      • 7.4.4.5 South Africa Veterinary Oncology Market
        • 7.4.4.5.1 South Africa Veterinary Oncology Market by Animal Type
        • 7.4.4.5.2 South Africa Veterinary Oncology Market by Therapy
        • 7.4.4.5.3 South Africa Veterinary Oncology Market by Cancer Type
      • 7.4.4.6 Nigeria Veterinary Oncology Market
        • 7.4.4.6.1 Nigeria Veterinary Oncology Market by Animal Type
        • 7.4.4.6.2 Nigeria Veterinary Oncology Market by Therapy
        • 7.4.4.6.3 Nigeria Veterinary Oncology Market by Cancer Type
      • 7.4.4.7 Rest of LAMEA Veterinary Oncology Market
        • 7.4.4.7.1 Rest of LAMEA Veterinary Oncology Market by Animal Type
        • 7.4.4.7.2 Rest of LAMEA Veterinary Oncology Market by Therapy
        • 7.4.4.7.3 Rest of LAMEA Veterinary Oncology Market by Cancer Type

Chapter 8. Company Profiles

  • 8.1 Boehringer Ingelheim International GmbH
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Partnerships, Collaborations, and Agreements:
      • 8.1.5.2 Acquisition and Mergers:
  • 8.2 Karyopharm Therapeutics, Inc.
    • 8.2.1 Company overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Research & Development Expenses
    • 8.2.4 Recent strategies and developments:
      • 8.2.4.1 Partnerships, Collaborations, and Agreements:
  • 8.3 Regeneus Ltd.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Research & Development Expense
  • 8.4 Elanco Animal Health, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Regional Analysis
    • 8.4.4 Research & Development Expenses
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Acquisition and Mergers:
  • 8.5 Zoetis, Inc.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Regional Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
  • 8.6 Varian Medical Systems, Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expense
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Acquisition and Mergers:
      • 8.6.5.2 Partnerships, Collaborations, and Agreements:
      • 8.6.5.3 Product Launches and Product Expansions:
  • 8.7 PetCure Oncology, LLC (Accelitech, LLC)
    • 8.7.1 Company Overview
    • 8.7.2 Recent strategies and developments:
      • 8.7.2.1 Partnerships, Collaborations, and Agreements:
  • 8.8 AB Science SA
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Research & Development Expense
  • 8.9 Rhizen Pharmaceuticals S.A.
    • 8.9.1 Company Overview
  • 8.1 Nippon Zenyaku Kogyo Co., Ltd.
    • 8.10.1 Company Overview